1. Aaron SD, Vandemheen KL, Boulet LP, et al. Overdiagnosis of asthma in obese and nonobese adults. CMAJ. 2008; 179:1121. [Full text].
  2. Agency for Healthcare Research and Quality. Treating tobacco use and dependence: 2008 update. U.S. Public Health Service. (Text Available)
  3. American Thoracic Society/European Respiratory Society. Standards for the Diagnosis and Management of Patients with COPD. 2004. Available at: http://www.thoracic.org/clinical/copd-guidelines/index.php. Accessed November 17, 2010.
  4. Anzueto A, Liemer I, Kesten S. Impact of frequency of COPD exacerbations on pulmonary function, health status, and clinical outcomes. Int J Chron Obstruct Pulmon Dis. 2009;4:245-251. [abstract]
  5. Barr RG, Celli BR, Mannino DM, et al. Comorbidities, patient knowledge, and disease management in a national sample of patients with chronic obstructive pulmonary disease. Am J Med. 2009; 122:348. (Abstract)
  6. Barr RG, Celli, BR, Martinez FJ, et al. for the COPD Resource Network Physician and Patient Perceptions in COPD. The COPD Resource Network Needs Assessment Survey. Am J Med. 2005; 118: 1415. (Abstract)
  7. Barreiro TJ, Perillo I. An approach to interpreting spirometry. Am Fam Physician. 2004;69:1107. (Abstract)
  8. Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54:581-586. (Abstract)
  9. British Thoracic Society Standards of Care Committee. BTS statement on criteria for specialist referral, admission, discharge, and follow-up for adults with respiratory disease. Thorax. 2008;63:i1-i16. [abstract]
  10. Burge S, Wedzicha JA. COPD exacerations: definitions and classifications. Eur Respir J. 2003; 21(suppl 41):46s [Abstract].
  11. Canadian Lung Association/Canadian Thoracic Society. Chronic obstructive pulmonary disease (COPD). A national report card. (Text Available)
  12. Celli, BR, MacNee, W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23:932. [Full text]
  13. Centers for Disease Control and Prevention. Smoking and tobacco use. Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion. (Text Available)
  14. Chandra D, Tsai CL, Camargo CA Jr. Acute exacerbations of COPD: delay in presentation and the risk of hospitalization. COPD. 2009;6:95-103. [Abstract]
  15. Dean MM. End-of-life care for COPD patients. Prim Care Respir J. 2008; 17:46. [abstract]
  16. Doherty DE, Chapman KR, Martinez FJ, et al. The value of early diagnosis for effective management of chronic obstructive disease. J Fam Pract. 2007; 56 (suppl 10):S1.
  17. Donohue JF. Therapeutic responses in asthma and COPD. Bronchodilators. Chest. 2004; 126(2 suppl):125S. [Abstract].
  18. El Moussaoui R, Roede BM, Speelman P, et al. Short-course antibiotic treatment in acute exacerbations of chronic bronchitis and COPD: a meta-analysis of double-blind studies. Thorax. 2008; 63:415. [Abstract]
  19. Fein A, Fein AM. Management of acute exacerbations in chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2000; 6:122. [Abstract].
  20. Fiore MC, Bailey WC, Cohen SJ, et al. Treating tobacco use and dependence. Rockville, Md.: U.S. Department of Health and Human Services, Public Health Service, 2000. (Text Available)
  21. Garcia-Vidal C, Almagro P, Romani V, et al. Pseudomonas aeruginosa in patients hospitalized for COPD exacerbation: a prospective study. Eur Respir J. 2009; 34:1072. [Abstract].
  22. Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax. 2009; 64:728. [Abstract].
  23. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2009). Available at: www.goldCOPD.com. Component 4: Manage exacerbations: 62-71.
  24. Irwin RS, Glomb WB, Chang AB. Habit cough, tic cough, and psychogenic cough in adult and pediatric populations. ACCP evidence-based clinical practice guidelines. Chest. 2006; 129(1 suppl):174S. [Full text].
  25. Kozower B, Lau C, Phillips J, et al. A thoracic surgeon-directed tobacco cessation intervention. Ann Thorac Surg. 2010;89:926-930. (Abstract)
  26. Mahler D, Wells C. Evaluation of clinical methods for rating dyspnea. Chest.1988;93:580-586. (Abstract)
  27. Miller MR, Crapo R, Hankinson J, et al. American Thoracic Society/European Respiratory Society Task Force: Standardisation of lung function testing. General considerations for lung function testing. Eur Respir J. 2005;26:153. (Ref)
  28. Montero M, Dominguez M, Orozco-Levi M, et al. Mortality of COPD patients infected with multi-resistant Pseudomonas aeruginosa: a case and control study. Infection. 2009; 37:16. [Abstract].
  29. Murphy TF. Pseudomonas aeruginosa in adults with chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2009; 15:138. [Abstract]. [Full Text]
  30. National Lung Health Education Program (NHLEP). (Text Available)
  31. Ohar JA, Hamilton RF Jr, Zheng S, et al. COPD is associated with a macrophage scavenger receptor-1 gene sequence variation. Chest. 2010; 137:1098. [Abstract].
  32. Niewoehner, DE, Erbland, ML, Deupree, RH, et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group [see comments]. N Engl J Med 1999; 340:1941. [Abstract]
  33. O'Donnell DE, Forkert L, Webb KA. Evaluation of bronchodilator responses in patients with "irreversible" emphysema. Eur Respir J. 2001; 18:914. [Abstract].
  34. Petty TL. Benefits of and barriers to the widespread use of spirometry. Curr Opin Pulm Med. 2005; 11:115. (Abstract)
  35. Rice KL, Dewan N, Bloomfield HE, et al. Disease management program for chronic obstructive pulmonary disease: a randomized controlled trial.  Am J Respir Crit Care Med. 2010; 182:890. [Abstract].
  36. Rodriguez-Roisin R. COPD exacerbations.5: management. Thorax. 2006;61:535-544. [Abstract]
  37. Scanlon PD, Connett JE, Waller LA, et al. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med. 2000; 161 (2 Pt 1): 381. (Abstract)
  38. Sciurba FC. Physiologic similarities and differences between COPD and asthma. Chest. 2004; 126(2 suppl):117S. [Full text].
  39. Shavelle RM, Paculdo DR, Kush SJ, Mannino DM, Strauss DJ. Life expectancy and years of life lost in chronic obstructive pulmonary disease: findings from the NHANES III Follow-up Study. Int J Chron Obstruct Pulmon Dis. 2009;4:137. (Abstract)
  40. Silva GE, Sherrill DL, Guerra S, Barbee RA. Asthma as a risk factor for COPD in a longitudinal study. Chest. 2004; 126:59. [Full text].
  41. Soler N, Agusti C, Angrill J, et al. Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease. Thorax. 2007; 62:29. [Abstract].
  42. Stockley RA, O'Brien C, Pye A, Hill SL. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. Chest. 2000; 117:1638. [Full Text].
  43. Straton, JB. Chief Medical Officer & Medical Director, Penn Wissahickon Hospice, University of Pennsylvania
  44. Tinkelman DG, Price DB, Nordyke RJ, et al. Symptom-based questionnaire for differentiating COPD and asthma. Respiration. 2006; 73:296. [Full text].
  45. Tinkelman DG, Price DB, Nordyke RJ, Halbert RJ. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over. J Asthma. 2006; 43:75. [Abstract].
  46. Tsimogianni AM, Papiris SA, Kanavaki S, et al. Predictors of positive sputum cultures in exacerbations of chronic obstructive pulmonary disease. Respirology. 2009;14:1114.  [Abstract].
  47. Wewers ME, Bailey WC, Carlsen KH. American Thoracic Society Subcommittee on Tobacco Control Initiatives. An Official American Thoracic Society workshop report: Tobacco control initiatives within the American Thoracic Society. Prooc Am Thorac Soc, 2010; 7:1. (Abstract).
  48. Wilkinson TM, Donaldson GC, Hurst JR, et al. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;169:1298-1303. [Abstract]
  49. Wilson R. Bacteria, antibiotics and COPD. Eur Respir J. 2001; 17:995. [Full Text].
  50. Yohannes AM. Palliative care provision for patients with chronic obstructive pulmonary disease. Health Qual Life Outcomes. 2007;5:17. [abstract]
Copyright © 2010-2013  Perelman School of Medicine at the University of Pennsylvania Office of Continuing Medical Education. All rights reserved.